Results 41 to 50 of about 27,340 (76)

MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach. [PDF]

J Cancer Res Clin Oncol, 2018
Schmoll HJ, Arnold D, de Gramont A, Ducreux M, Grothey A, O'Dwyer PJ, Van Cutsem E, Hermann F, Bosanac I, Bendahmane B, Mancao C, Tabernero J.   +11 more
europepmc   +1 more source

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib. [PDF]

Oncotarget, 2018
Jiménez-Fonseca P, Martín MN, Carmona-Bayonas A, Calvo A, Fernández-Mateos J, Redrado M, Capdevila J, Lago NM, Lacasta A, Muñarriz J, Segura Á, Fuster J, Barón F, Llanos M, Serrano R, Castillo A, Cruz Hernández JJ, Grande E.   +17 more
europepmc   +1 more source

First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study. [PDF]

Oncologist, 2012
Díaz-Rubio E, Gómez-España A, Massutí B, Sastre J, Abad A, Valladares M, Rivera F, Safont MJ, Martínez de Prado P, Gallén M, González E, Marcuello E, Benavides M, Fernández-Martos C, Losa F, Escudero P, Arrivi A, Cervantes A, Dueñas R, López-Ladrón A, Lacasta A, Llanos M, Tabernero JM, Antón A, Aranda E, Spanish Cooperative Group for the Treatment of Digestive Tumors.   +25 more
europepmc   +1 more source

One Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone. [PDF]

Am J Trop Med Hyg, 2015
Richards F, Rizzo N, Diaz Espinoza CE, Monroy ZM, Crovella Valdez CG, de Cabrera RM, de Leon O, Zea-Flores G, Sauerbrey M, Morales AL, Rios D, Unnasch TR, Hassan HK, Klein R, Eberhard M, Cupp E, Domínguez A.   +16 more
europepmc   +1 more source

Combining statistical techniques to predict postsurgical risk of 1-year mortality for patients with colon cancer. [PDF]

Clin Epidemiol, 2018
Arostegui I, Gonzalez N, Fernández-de-Larrea N, Lázaro-Aramburu S, Baré M, Redondo M, Sarasqueta C, Garcia-Gutierrez S, Quintana JM, REDISSEC CARESS-CCR Group.   +9 more
europepmc   +1 more source

Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status. [PDF]

JAMA Oncol, 2018
Taieb J, Kourie HR, Emile JF, Le Malicot K, Balogoun R, Tabernero J, Mini E, Folprecht G, Van Laethem JL, Mulot C, Bouché O, Aparicio T, Michel P, Thaler J, Bridgewater J, Van Cutsem E, Perkins G, Lepage C, Salazar R, Laurent-Puig P, Pan-European Trials in Alimentary Tract Cancer (PETACC)-8 Investigators.   +20 more
europepmc   +1 more source